Angel Romero

Dr. Angel Romero

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications


1 March 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
ARAngel Romero
Angel Romero
NRNoris Rodríguez
Noris Rodríguez
HOHenry Oviedo
Henry Oviedo

5 March 2019 in Topics in Current Chemistry
Verified
Journal Article
Closed access
PDF file
ARAngel Romero
Angel Romero

1 February 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ARAngel Romero
Angel Romero
RMRafael Medina
Rafael Medina
AAAnamaría Alcala
Anamaría Alcala
YGYael García-Marchan
Yael García-Marchan
JNJorge Núñez-Duran
Jorge Núñez-Duran
SLSimón E. López
Simón E. López

25 February 2022 in ACS Omega
Verified
Journal Article
Open access
MAMaría E. Acosta
María E. Acosta
LGLourdes Gotopo
Lourdes Gotopo
NGNeira Gamboa
Neira Gamboa
JRJuan R. Rodrigues
Juan R. Rodrigues
GHGenesis C. Henriques
Genesis C. Henriques
ARAngel Romero
Angel Romero
The β-hematin formation is a unique process adopted by Plasmodium sp. to detoxify free heme and represents a validated target to design new effective antimalarials. Most of the β-hematin inhibitors are mainly based on 4-aminoquinolines, but the parasite has developed diverse defense mechanisms against this type of chemical system. Thus, the identification of other molecular chemical entities targeting the β-hematin formation pathway is highly needed to evade resistance mechanisms associated with 4-aminoquinolines. Herein, we showed that the highly coordinative character can be a useful tool for the rational design of antimalarial agents targeting β-hematin crystallization. From a small library consisting of five compound families with recognized antitrypanosomatid activity and coordinative abilities, a group of tetradentate 1,4-disubstituted phthalazin-aryl/heteroarylhydrazinyl derivatives were identified as potential antimalarials. They showed a remarkable curative response against Plasmodium berghei-infected mice with a significant reduction of the parasitemia, which was well correlated with their good inhibitory activities on β-hematin crystallization (IC50 = 5–7 μM). Their in vitro inhibitory and in vivo responses were comparable to those found for a chloroquine reference. The active compounds showed moderate in vitro toxicity against peritoneal macrophages, a low hemolysis response, and a good in silico ADME profile, identifying compound 2f as a promising antimalarial agent for further experiments. Other less coordinative fused heterocycles exhibited moderate inhibitory responses toward β-hematin crystallization and modest efficacy against the in vivo model. The complexation ability of the ligands with iron(III) was experimentally and theoretically determined, finding, in general, a good correlation between the complexation ability of the ligand and the inhibitory activity toward β-hematin crystallization. These findings open new perspectives toward the rational design of antimalarial β-hematin inhibitors based on the coordinative character as an alternative to the conventional β-hematin inhibitors.